Medicine guide
Mysimba 8 mg/90 mg tabletten met verlengde afgifte
As listed in the register: Mysimba 8 mg/90 mg tabletten met verlengde afgifte
8 mg + 90 mg · tablet met verlengde afgifte
- Prescription only
- Digestion, stomach, diabetes and nutrition
- Active substance
- Bupropionhydrochloride + Naltrexonhydrochloride
- Made by
- Orexigen Therapeutics Ireland Limited
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Medicine groupDigestion, stomach, diabetes and nutritionA08AA62
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | Orexigen Therapeutics Ireland Limited |
|---|---|
| Active substance | Bupropionhydrochloride + Naltrexonhydrochloride |
| Used in | Digestion, stomach, diabetes and nutrition |
| Strength | 8 mg + 90 mg |
| Form | tablet met verlengde afgifte |
| Classification | A08AA62 · Digestion, stomach, diabetes and nutrition |
| Route | oraal gebruik |
| Dispensing (as stated by the register) | Uitsluitend recept |
| RVG | EU/1/14/988 |
Source: Geneesmiddeleninformatiebank · 2026-09-30 · not reviewed by a clinician
Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site. Reuse terms: CC0 1.0 (CBG website).